Avastin Falls Short In Treatment Of Ovarian Cancer | WAMU 88.5 - American University Radio

NPR : News

Filed Under:

Avastin Falls Short In Treatment Of Ovarian Cancer

Cancer-fighter Avastin just came up short as a treatment for ovarian tumors.

Two studies found that the drug, which blocks the formation of new blood vessels, didn't extend the lives of patients with ovarian cancer.

Avastin did slow the progression of the cancers a little bit. But the patients getting Avastin as part of treatment with several medicines had more side effects, including blood clots and high blood pressure, than the people who didn't get it.

Sound familiar? The Food and Drug Administration recently withdrew the approval for Avastin as a treatment for breast cancer concluding, in the words of Commissioner Margaret Hamburg, that "there is no benefit to breast cancer patients that would justify its risks."

As it happens, Roche's Genentech unit, maker of the Avastin, just got approval from European regulators for use of the drug in treating advanced ovarian cancer.

But after talking things over with the Food and Drug Administration Genentech isn't rushing to do the same in the U.S., the Associated Press reports. "We do not believe the data will support approval," a Genentech spokeswoman told the AP. Still, the company hasn't made a final decision.

Despite these setbacks, Avastin remains a stalwart in the treatment of colorectal and lung cancer. The drug, which can cost up $100,000 for a year of treatment, is also approved in the U.S. for brain and kidney cancers.

The studies, published in the latest New England Journal of Medicine, can be found here and here.

Copyright 2011 National Public Radio. To see more, visit http://www.npr.org/.

WAMU 88.5

Art Beat With Lauren Landau, Jan. 27, 2015

You can see a play about a girl whose world shifts from black and white to full color. An exhibit of abstract paintings is on view in D.C.

NPR

Sandwich Monday: Girl Scout Cookie Coffeemate

For this week's Sandwich Monday, we try Girl Scout Cookies in a new form. Coffeemate has somehow blended them into nondairy creamer, so you can start your day the disturbing way.
WAMU 88.5

Plan To Limit License Plate Tracking In Virginia Gets Bipartisan Support

Technology allows Virginia police officers to scan the license plates of passing drivers, but lawmakers want to limit how long they're allowed to hold onto that information.

NPR

Facebook Suffers Self-Inflicted Outage

A Facebook statement said the disruption was caused by a technical change it made to the site and wasn't a cyberattack. The outage lasted an hour.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.